Literature DB >> 20690093

Clinical utility of serum cystatin C in predicting coronary artery disease.

Mevlut Koc1, Mustafa Kemal Batur, Osman Karaarslan, Gülcan Abali.   

Abstract

BACKGROUND: There is limited data regarding the clinical utility of cystatin C in patients with stable coronary artery disease (CAD). The aim of this study was to determine the predictive value of cystatin C for the presence and severity of CAD and the association between this protein and other biochemical risk factors for atherosclerosis in patients with suspected CAD.
METHODS: Ninety-four patients with CAD, and 92 patients without CAD but with cardiovascular risk factors, were included in this study. Echocardiography and other pertinent laboratory examinations were performed. Subjects were divided into four groups according to their cystatin C quartile. Cystatin C groups were analyzed for the association with CAD characteristics.
RESULTS: The number of patients with CAD increased as the quartile of cystatin C increased, and there was a remarkable difference between quartiles (p < 0.001). Logistic regression analysis revealed independent predictors of incident CAD as cystatin C, hs-CRP, eGFR, HDL cholesterol and SBP (p = 0.005, p = 0.027, p = 0.017, p = 0.014 and p = 0.001, respectively). Moreover, cystatin C concentration was significantly correlated with CAD severity score (b = 0.258, p < 0.01). A cut-off value of 0.82 mg/L for cystatin C predicted incident CAD with a sensitivity and specificity of 75.5% and 75.0% respectively. Cystatin C concentration also correlated well with the atherosclerotic biochemical risk factors like homocysteine, creatinine and hs-CRP.
CONCLUSIONS: Cystatin C could be a useful laboratory tool in predicting the presence and severity of CAD in daily practice. It also correlates significantly with biochemical risk factors for CAD, namely homocysteine, low HDL and CRP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20690093

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  12 in total

1.  Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.

Authors:  Min Ji Shin; Sang Heon Song; Ihm Soo Kwak; Soo Bong Lee; Dong Won Lee; Eun Young Seong; Il Young Kim; Harin Rhee; Naria Lee
Journal:  Clin Exp Nephrol       Date:  2012-01-26       Impact factor: 2.801

2.  The potential of Cystatin C and small dense LDL as biomarkers of coronary artery disease risk in a young Indian population.

Authors:  Anjali Manocha; Flora Gupta; Rajneesh Jain; Seema Bhargava; Mamta Kankra; Sabari Das; L M Srivastava
Journal:  Mol Cell Biochem       Date:  2013-12-20       Impact factor: 3.396

3.  Serum extracellular vesicle protein levels are associated with acute coronary syndrome.

Authors:  Vince C de Hoog; Leo Timmers; Arjan H Schoneveld; Jiong-Wei Wang; Sander M van de Weg; Siu Kwan Sze; J Karlijn van Keulen; Arno W Hoes; Hester M den Ruijter; Dominique Pv de Kleijn; Arend Mosterd
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

4.  Serum biomarkers and the prognosis of AMI patients.

Authors:  S Wei; L Mao; B Liu; L Zhong
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

5.  Comparison of heritability of Cystatin C- and creatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease.

Authors:  Johannes Arpegård; Alexander Viktorin; Zheng Chang; Ulf de Faire; Patrik K E Magnusson; Per Svensson
Journal:  J Am Heart Assoc       Date:  2015-01-14       Impact factor: 5.501

6.  Cystatin C: A prognostic marker after myocardial infarction in patients without chronic kidney disease.

Authors:  Leila Abid; Salma Charfeddine; Samir Kammoun; Mouna Turki; Fatma Ayedi
Journal:  J Saudi Heart Assoc       Date:  2015-10-09

7.  Arterial indices and serum cystatin C level in individuals with occupational wide band noise exposure.

Authors:  Ali R Khoshdel; Benyamin Mousavi-Asl; Babak Shekarchi; Kazem Amini; Iraj Mirzaii-Dizgah
Journal:  Noise Health       Date:  2016 Nov-Dec       Impact factor: 0.867

8.  Clinical application of simultaneous detection of cystatin C, cathepsin S, and IL-1 in classification of coronary artery disease.

Authors:  Ling Yan; Shuang Ding; Bing Gu; Ping Ma
Journal:  J Biomed Res       Date:  2017-07-13

9.  Cystatin C may not be a precious predictor for coronary artery disease and its severity: an area of uncertainty.

Authors:  Hossein Vakili; Abdollah Mohamadian; Mohammadreza Naderian; Isa Khaheshi
Journal:  Acta Biomed       Date:  2018-06-07

10.  Body mass index and waist/height ratio for prediction of severity of coronary artery disease.

Authors:  Khandker Md Nurus Sabah; Abdul Wadud Chowdhury; H I Luftur Rahman Khan; A T M Hasibul Hasan; Serajul Haque; Shomsher Ali; Shamima Kawser; Nur Alam; Gaffar Amin; S M Ear E Mahabub
Journal:  BMC Res Notes       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.